Nuntius Therapeutics (private company)

See something wrong or missing? Let us know
Offices:London
Industry:Biotech
Business model:B2B

Nuntius Therapeutics is a biotech company working for producing therapies for currently incurable rare diseases.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 125k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Nuntius Therapeutics

Name Criteria
Switzerland CyanoGuard
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Olombria
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Norway Age Labs AS
36%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Lithuania Biomatter Designs
36%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Merozyne Therapeutics
36%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden VOC Diagnostics
36%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Denmark Pipe|bio
36%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Valink Therapeutics
36%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Achilles Therapeutics
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Belgium Aphea.Bio
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Top